guaiacol has been researched along with Hyperlipemia in 5 studies
Guaiacol: An agent thought to have disinfectant properties and used as an expectorant. (From Martindale, The Extra Pharmacopoeia, 30th ed, p747)
methylcatechol : Any member of the class of catechols carrying one or more methyl substituents.
guaiacol : A monomethoxybenzene that consists of phenol with a methoxy substituent at the ortho position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperlipidemia represents a major risk factor for cardiovascular diseases leading to myocardial injury (MI)." | 1.56 | Early myocardial injury biomarkers in diabetic hyperlipidemic rats: Impact of 10-dehydrogingerdione and vitamin D3. ( Aly, SI; Elseweidy, MM; Hammad, SK; Shershir, NI, 2020) |
| "Pretreatment with zingerone prevented hyperlipidaemia and cardiac hypertrophy, by virtue of its antihyperlipidaemic, antihypertrophic, and reducing properties in isoproterenol-induced myocardial infarcted rats." | 1.42 | Antihyperlipidaemic, antihypertrophic, and reducing effects of zingerone on experimentally induced myocardial infarcted rats. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2015) |
| "Guaiacol was chosen as a reference substance due to its high ability to co-oxygenate." | 1.38 | The impact of Triton WR-1339 induced hyperlipidemia on the effects of benzo(a)pyrene or guaiacol on α- and γ-tocopherol pools and selected markers of pro-/antioxidative balance in rat plasma and erythrocytes. ( Brandys, J; Gawlik, M; Gawlik, MB, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elseweidy, MM | 3 |
| Aly, SI | 1 |
| Hammad, SK | 1 |
| Shershir, NI | 1 |
| Elswefy, SE | 2 |
| Younis, NN | 2 |
| Tarek, S | 2 |
| Hemalatha, KL | 1 |
| Stanely Mainzen Prince, P | 1 |
| Gawlik, M | 1 |
| Gawlik, MB | 1 |
| Brandys, J | 1 |
5 other studies available for guaiacol and Hyperlipemia
| Article | Year |
|---|---|
Early myocardial injury biomarkers in diabetic hyperlipidemic rats: Impact of 10-dehydrogingerdione and vitamin D3.
Topics: Animals; Aorta; Biomarkers; Blood Glucose; Cholecalciferol; Diabetes Mellitus, Experimental; Fatty A | 2020 |
The modulation of PCSK-9 and GAGs by 10-dehydrogingerdione and pentoxifylline in hyperlipidemic rabbits.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Cholesterol; Glycosaminoglycans; Guaiacol; Hyper | 2020 |
Contribution of aorta glycosaminoglycans and PCSK9 to hyperlipidemia in experimental rabbits: the role of 10-dehdrogingerdione as effective modulator.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Atorvastatin; Cholesterol; Glycosaminogly | 2019 |
Antihyperlipidaemic, antihypertrophic, and reducing effects of zingerone on experimentally induced myocardial infarcted rats.
Topics: Animals; Cardiomegaly; Guaiacol; Hyperlipidemias; Hypolipidemic Agents; Isoproterenol; Male; Myocard | 2015 |
The impact of Triton WR-1339 induced hyperlipidemia on the effects of benzo(a)pyrene or guaiacol on α- and γ-tocopherol pools and selected markers of pro-/antioxidative balance in rat plasma and erythrocytes.
Topics: alpha-Tocopherol; Animals; Benzo(a)pyrene; Carcinogens; Erythrocytes; gamma-Tocopherol; Guaiacol; Hy | 2012 |